Bill · H.R. 4139· House(119-HR-4139)
Cutting Copays Act
- Introduced
- 6/25/2025
- Last activity
- 6/25/2025 — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Sponsored by
- Morgan McGarvey
- Cosponsors
- - 0 - 1
- Introduced
- In Committee
What this bill would do
This bill, known as the "Cutting Copays Act," aims to amend the Social Security Act regarding Medicare Part D. It specifically targets cost-sharing reductions for low-income individuals. The legislation seeks to adjust copayment amounts for various types of drugs. These adjustments include specific rules for plan years before 2026 and the plan year 2026 itself. It also establishes a method for adjusting these amounts in subsequent years based on the consumer price index.
Yes· 3 of 6
Would people over 65 be better off under this?+8
The bill provides significant copayment reductions for Medicare Part D drugs, which heavily benefits seniors.
Would retired people be better off under this?+8
The reduction in Medicare Part D drug copayments directly benefits retirees.
Would households on low incomes be better off under this?+7
The bill lowers the cost of prescription drugs specifically for low-income individuals.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Reduced costs for generic drugs in 2026: For the plan year 2026, the copayment for a generic drug is set to $0 (Section 2).
-
Defined copayment limits for years before 2026: For plan years before 2026, the bill sets a limit of $1 for generic or certain preferred drugs, and $3 for other drugs (Section 2).
Potential Negative Impacts for People
-
Potential cost increases for non-generic drugs in 2026: For the plan year 2026, the copayment for any drug other than a generic is determined by the dollar amount applied for the year 2023 (Section 2).
-
Future cost increases based on inflation: For subsequent years, drug copayments may increase based on the annual percentage increase in the consumer price index (Section 2).
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Demographic And Interest Groups
- Good For Retirees+8Good For Seniors+8Good For Low Income Households+7
- Social Issues And Justice
- Improves Social Security+5Improves Poverty Reduction+3
- Healthcare
- Reduces Prescription Drug Costs+7
- 6/25/2025
- Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 1 Cosponsor added.
- Introduced in House
Gus BilirakisRepublican · Florida